Doxy-PEP keeps San Francisco at forefront of STD prevention

San Francisco, a decadeslong global leader in HIV/AIDS treatment, remains on the forefront of STD prevention thanks to a pill shown to reduce the risk of spreading chlamydia, gonorrhea and syphilis.

Related Keywords

Kenya , San Francisco , California , United States , Annie Luetkemeyer , Research On , Foundation Strut Clinic , Drug Administration , Department Of Public Health , Centers For Disease , University Of Washington , Oliver Bacon , San Francisco City Clinic , Zuckerberg San Francisco General Hospital , Disease Control , New England Journal , Zuckerberg General , Public Health , Sexually Transmitted Diseases , Hiv And Aids , Csf ,